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Abstract 27 
Steroid hormones can exist in functionally-dissociable sulfated and non-sulfated (free) 28 
forms and can exert profound effects on numerous aspects of mammalian physiology; the 29 
ratio of free to sulfated steroids is governed by the antagonistic actions of steroid sulfatase 30 
(STS) and sulfotransferase (SULT) enzymes. Here, I examine evidence from human and 31 
animal model studies which suggests that STS and its major substrate 32 
(dehydroepiandrosterone sulfate, DHEAS) and product (DHEA) can influence brain function, 33 
behavior and mental health, before summarising how the activity of this axis varies 34 
throughout mammalian pregnancy and the postpartum period. I then consider how the 35 
steroid sulfate axis might impact upon normal maternal behavior and how its dysfunction 36 
might contribute towards risk of postpartum psychiatric illness. Understanding the 37 
biological substrates underlying normal and abnormal maternal behavior will be important 38 
for maximising the wellbeing of new mothers and their offspring.          39 
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An introduction to the steroid sulfate axis 53 
Steroid hormones are synthesised within a number of endocrine body tissues (notably the 54 
adrenal gland, gonadal, breast, adipose and liver tissue in primates), and, as well as being 55 
utilised locally, may subsequently transported elsewhere to elicit widespread physiological 56 
effects. The hydrophobicity of free steroids limits their ability to be transported within 57 
aqueous media; hence, transport of these compounds is faciliated by the addition of 58 
negatively-charged sulfate groups through esterification by the steroid sulfotransferase 59 
(SULT) enzymes SULT1E1, SULT2A1, or SULT2B1b, or, to a lesser extent, by SULT1A1 or 60 
SULT2B1a (Salman et al. 2011, Mueller et al. 2015). In addition to increasing the solubility of 61 
steroids, sulfation processes also increase their stability: circulating concentrations of sulfated 62 
steroids are typically substantially higher than circulating concentrations of their free steroid 63 
counterparts, and the former may act as ‘reservoirs’ for the peripheral formation of bioactive 64 
hormones (Mueller et al. 2015). Many common steroids can be sulfated including cholesterol, 65 
pregnenolone, estrone and dehydroepiandrosterone (DHEA) (Mueller et al. 2015).  66 
Upon influx into cells in target tissues via organic anion transporter proteins, sulfated 67 
steroids are typically desulfated by hydrolysis to their unconjugated forms, which are 68 
generally considered to be more biologically-active and which can act as precursors for a 69 
variety of androgens and estrogens. Whilst multiple sulfotransferases can facilitate sulfation 70 
according to tissue-type, there is just one ubiquitous enzyme which cleaves sulfate groups 71 
from steroids: steroid sulfatase (STS, formerly known as arylsulfatase C). In the interests of 72 
clarity and brevity, in this review I focus upon the physiological roles of STS and 73 
dehydroepiandrosterone (DHEA), whose sulfated form (DHEAS) is the most abundant 74 
circulating steroid in humans (Neunzig & Bernhardt 2014). 75 
 76 
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Steroid sulfatase: its regulation, expression and function 77 
Steroid sulfatase is encoded by the X-linked STS gene (Xp22.3). As the human STS gene 78 
escapes X-inactivation (Shapiro et al. 1979), and as its Y-linked paralogue is pseudogenic (Yen 79 
et al. 1988), expression of STS is 1-2fold higher in female than male tissues (including brain) 80 
during development and into adulthood, although whether this expression difference 81 
translates to significantly greater enzyme activity in female tissues is debatable (Cuevas-82 
Covarrubias et al. 1993, Miranda-Duarte et al. 1999, Ugele & Regemann 2000, Nakamura et 83 
al. 2003, Steckelbroek et al. 2004, Kriz et al. 2008, HE O’Brien et al. manuscript in preparation); 84 
nevertheless, the possibility certainly exists that the physiological consequences of STS 85 
activity modulation could feasibly be more profound in women than in men. STS is expressed 86 
in a number of tissues many of which are involved in reproductive function, including: the 87 
placenta (highest expression), brain, ovary, mammary gland, testis, adipose tissue, thyroid 88 
gland and skin (Salido et al. 1990, Miki et al. 2002, Steckelbroek et al. 2004, Stergiakouli et al. 89 
2011, https://www.ncbi.nlm.nih.gov/unigene accessed 12th September 2017).  90 
At the cellular level, the STS protein is largely located in the endoplasmic reticulum of 91 
the cell where it functions as a glycosylated homodimer; the catalytic activity of STS is 92 
dependent upon the presence of sulfatase-modifying factors (SUMFs) (Mueller et al. 2015). 93 
STS activity appears to be increased in response to stress/inflammation in various tissues with 94 
the gene being a target of NF-κB; the resultant free steroid products, notably estrogens, may 95 
act as inflammation-suppressors (Dias & Selcer 2016, Jiang et al. 2016). STS has long been 96 
recognised as a therapeutic target in hormone-dependent cancers, and a number of effective 97 
and specific STS inhibitors have been developed which reduce the pool of androgens and 98 
estrogens in the vicinity of the cancer and which have potential clinical benefits (Purohit & 99 
Foster 2012).      100 
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The steroid sulfatase axis: its influence on brain function and behavior 101 
Seminal work in rodents suggested that, in mammals, some steroids (and hence their sulfate 102 
conjugates) such as DHEA(S) could be synthesised de novo in the brain and may be regarded 103 
as neurosteroids (Corpechot et al. 1981). Subsequent work has shown that, whilst DHEA 104 
biosynthesis within the brain is possible, a second route by which DHEA appears in the brain 105 
in rodents (and feasibly humans too) is through the uptake, and subsequent rapid desulfation, 106 
of circulating DHEAS by organic ion transporters and steroid sulfatase respectively in the 107 
capillaries of the blood-brain barrier (Qaiser et al. 2017). Whilst the expression patterns of 108 
STS in the human blood-brain barrier have yet to be systematically assessed, in the developing 109 
human brain, STS is highly expressed throughout the thalamus with lower expression also 110 
seen in the olfactory epithelium, the cerebral cortex, the basal ganglia, the hypothalamus and 111 
pituitary gland, the choroid plexus and the cerebellar neuroepithelium (Stergiakouli et al. 112 
2011); in adulthood, high levels of STS expression and associated enzyme activity persist in 113 
these regions (Perumal et al. 1973, Steckelbroeck et al. 2004, Kriz et al. 2008). Although STS 114 
activity in the brain is likely to have important and widespread developmental and ongoing 115 
effects (see later), sulfatase activity in this tissue is apparently dominated by sulfotransferase 116 
activity, and, in support of this idea, levels of sulfated steroids in the human brain  (including 117 
those of DHEAS) may be relatively high (Maninger et al. 2009, Mueller et al. 2015).    118 
At the molecular level, free and sulfated steroid hormones can modulate receptors 119 
influencing acute neuronal inhibition and excitation, as well as neurodevelopmental 120 
processes. For example, both DHEAS and pregnenolone sulfate act as antagonists at GABAA 121 
receptors, as agonists at σ receptors, and as positive modulators at N-methyl-D-aspartic acid 122 
(NMDA) receptors (Reed et al. 2005, Qaiser et al. 2017). Importantly, the sulfated and 123 
unconjugated steroids may have differential effects and potencies e.g. DHEA has been 124 
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reported to act as a weaker GABAA antagonist than DHEAS (Reed et al. 2005, Maninger et al. 125 
2009). In addition to relatively weak agonistic effects at the androgen and estrogen receptors, 126 
DHEA and DHEAS may bind to, and activate, neurotrophin TrkA and p75NTR receptors to 127 
attenuate neuronal apoptosis and hence influence neurodevelopment (Lazaridis et al. 2011).  128 
Insights into the behavioral and brain processes that are mediated by STS and 129 
DHEA(S), potentially via the aforementioned molecular mechanisms, can be obtained by 130 
examining phenotypes in individuals in which: a) the STS gene is rendered non-functional (by 131 
natural or experimental means), b) the STS enzyme is acutely inhibited by a selective drug, or 132 
c) DHEA(S) has been administered. Less convincingly, it is possible to investigate the extent to 133 
which (peripheral) levels of DHEA(S) correlate with brain/ behavioral phenotypes of interest, 134 
and hence the extent to which changes in the former may cause the latter.  135 
In humans, STS deficiency (arising from partial or complete deletion of the gene, or 136 
inactivating point mutations within it) results in the rare dermatological condition X-linked 137 
ichthyosis (XLI) (Fernandes et al. 2010). XLI chiefly affects males, and is associated with an 138 
elevated DHEAS/DHEA serum ratio, especially pre-pubertally (Idkowiack et al. 2016). Whilst 139 
there is currently little published literature on brain structure/function and biochemistry in 140 
individuals with XLI (Trent & Davies 2013), there is an emerging literature suggesting that boys 141 
with the condition may be at increased risk of developmental disorders such as Autism 142 
Spectrum Conditions (ASCs), Attention Deficit Hyperactivity Disorder (ADHD), and early-onset 143 
psychotic disorders (Kent et al. 2008, Chatterjee et al. 2016, Malik et al. 2017) whilst men with 144 
the condition may be at increased risk of both developmental and mood (unipolar depression 145 
and bipolar) disorders (Chatterjee et al. 2016). There is also some evidence that genetic 146 
variation within STS is associated with measures of attention in both clinical (ADHD) (Brookes 147 
et al. 2010, Stergiakouli et al. 2011, Wang et al. 2017) and healthy (Humby et al. 2017) 148 
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populations. These behavioral findings are consistent with the high expression of STS in brain 149 
regions involved in integrating and acting upon sensory information, and executive function.  150 
Recapitulating the clinical findings in XLI, mice in which the Sts gene is deleted (or in 151 
which the STS enzyme is inhibited) show significantly reduced levels of serum DHEA and 152 
associated impairments in attention, altered response inhibition, hyperactivity, heightened 153 
emotional reactivity and aggression, and increased levels of behavioral perseveration (Davies 154 
et al. 2009, Trent et al. 2012b, Trent et al. 2013, Davies et al. 2014). Animal models allow the 155 
neurochemistry underlying behavioral abnormalities to be studied. Sts deletion in mice is 156 
associated with higher serotonin levels in the striatum and hippocampus (together with 157 
elevated hippocampal expression of the serotonin receptor 2c (Htr2c) gene), and reduced 158 
striatal noradrenaline turnover; the extent of serotonergic perturbation in Sts-deficient mice 159 
seems to correlate with the severity of some behavioral phenotypes (Trent et al. 2012a). 160 
Pharmacological studies in rats in which the STS enzyme was acutely inhibited have revealed 161 
changes in hippocampal acetylcholinergic release together with parallel changes in memory 162 
function (Rhodes et al. 1997, Babalola et al. 2012, Yue et al. 2016).  163 
Experimental and correlational studies in animal models and human populations have 164 
linked altered DHEA(S) levels to a diverse and important range of behavioral phenotypes 165 
including: sexual function (Peixoto et al. 2017), aggression (Nicolas et al. 2001, Soma et al. 166 
2015), locomotor activity (Strous et al. 2001, Trent et al. 2012b, Trent et al. 2013) and 167 
numerous aspects of mood and cognition (including attention) (Rhodes et al. 1996, Davies et 168 
al. 2009, Pluchino et al. 2015, Starka et al. 2015). 169 
The data presented above establish that steroid sulfatase (and its dysfunction) can 170 
impact extensively upon normal brain function via multiple neural and neurochemical 171 
pathways; this action may be direct (i.e. within the brain itself), or, alternatively, may result 172 
8 
 
from extra-brain STS activity impacting upon the production and action of circulating levels of 173 
sulfated and free steroids including DHEA(S).  174 
Changes in the steroid sulfate axis throughout mammalian pregnancy and the postpartum 175 
period 176 
Throughout the childbearing process, women experience considerable hormonal 177 
fluctuations, including with regard to the steroid sulfate axis (Tal et al. 2000). However, 178 
longitudinal studies in which the levels, and sulfation status, of multiple hormones are 179 
measured across pregnancy and the postpartum period are scarce. Due to ethical and 180 
practical issues, most information in humans comes from analysis of peripheral tissues (blood, 181 
serum/ plasma, saliva and rarely cerebrospinal fluid) and therefore its relevance to the 182 
hormonal milieu experienced directly by the brain is questionable. Moreover, peripherally-183 
detected maternal hormone levels may be influenced by multiple variable factors including: 184 
breastfeeding, stress exposure, use of recreational and therapeutic drugs, parity, maternal 185 
age and diet, and gender/number/size of the fetus(es), and understanding how unstable 186 
hormone levels relate to specific physiological phenotypes is therefore challenging. Whilst the 187 
use of neurobiologically-amenable mammalian animal models in which experimental 188 
variables can be controlled may circumvent these issues to some extent in in vivo systems, 189 
such models differ from humans in terms of both circulating hormone levels and reproductive 190 
traits such as number of offspring per pregnancy, or the extent and duration of postnatal 191 
maternal care; hence, extrapolating from models to man (or woman) should be done with 192 
caution.  193 
In humans, from around nine weeks of pregnancy, a key role of the steroid sulfate axis 194 
is to generate precursors for the production of estrogens to be secreted into the maternal 195 
and fetal bloodstreams. Initially, sulfated C-19 steroids including DHEAS and 16α-OH-DHEAS 196 
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produced by the maternal and fetal adrenal glands and fetal liver must undergo hydrolyis in 197 
the STS-rich syncytiotrophoblast of the placenta (Salido et al. 1990) before conversion by a 198 
series of enzymatic reactions to estrogens including estrone, estriol and estradiol; estrone, 199 
but not estradiol, is subsequently sulfated in the mother (Geyer et al. 2017).  200 
As healthy pregnancies progress, there is a consistently-observed decrease in 201 
maternal DHEAS serum levels from non-pregnancy levels (apparently independent of fetal 202 
gender), perhaps as DHEAS is increasingly utilised for estrogen synthesis in the developing 203 
placenta; after parturition, maternal serum DHEAS levels rapidly rebound to pre-pregnancy 204 
levels (Tagawa et al. 2004, Soldin et al. 2005, Kuijper et al. 2013, Farrar et al. 2014). The data 205 
regarding systemic maternal DHEA levels throughout pregnancy and the postpartum period 206 
are less consistent. Some studies have demonstrated elevated serum/plasma DHEA levels 207 
during early-mid pregnancy, with a subsequent gradual decline up to one year postpartum 208 
(Nieschlag et al. 1974, Buckwalter et al. 1999, Tagawa et al. 2004); given DHEA’s 209 
immunosuppressive effects and an increase in maternal cytokine markers after childbirth, this 210 
pattern of effects has been postulated to provide maximum protection for the incipient fetus 211 
from maternal immune surveillance (Tagawa et al. 2004). Other studies have suggested that 212 
peripheral DHEA levels are relatively unaffected by pregnancy and parturition (Buster et al. 213 
1979, Soldin et al. 2005) or even that they increase across pregnancy and towards parturition 214 
in peripheral tissues (saliva or plasma) (Bird et al. 1980, Hampson et al. 2013). If DHEAS levels 215 
do fluctuate as outlined above during pregnancy/postpartum period, and DHEA levels remain 216 
in a comparatively steady state, then the DHEA/DHEAS ratio would be expected to be high 217 
during pregnancy and low during the postpartum period relative to values in non-pregnancy; 218 
in healthy populations where this ratio has been assessed longitudinally, this pattern of 219 
effects is indeed observed (Hill et al. 2002, Tagawa et al. 2004).   220 
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Presumably the above changes in DHEA/DHEAS ratio over the course of pregnancy 221 
and the postpartum period are related to the relative abundance and/or activity of the steroid 222 
sulfatase and sulfotransferase enzymes in cells contributing towards the hormonal milieu of 223 
the periphery. A main contributor to this ratio is the syncytiotrophoblast cells of the placenta, 224 
and expulsion of the STS-rich placenta after birth likely explains the rapid restoration of 225 
circulating maternal DHEAS levels. However, other tissues may also contribute: in healthy 226 
women, STS activity in leukocytes has been reported to be greater in third trimester pregnant 227 
women than in first trimester pregnant, or non-pregnant, women (Miyakawa et al. 1994), a 228 
finding consistent with the observed high DHEA/DHEAS ratio during late pregnancy. To the 229 
best of my knowledge, there has not yet been any systematic analysis of peripheral 230 
(leukocyte) STS activity throughout the postpartum period in humans.  231 
Peripheral levels of sulfated and free steroids cannot  provide reliable information on 232 
the activity of steroid sulfatase in the brain, and direct measurement of brain STS activity 233 
throughout pregnancy and the postpartum period in humans is currently unachievable. 234 
However, animal models, such as rodents, might provide some insights into human 235 
physiology (bearing in mind the caveats discussed above with respect to cross-species 236 
extrapolation). Mortaud and colleagues (1996) showed that, in whole female mouse brain, 237 
STS protein levels were more than two-fold higher in the lactating (postpartum) state relative 238 
to the pregnant (stage not specified) or non-pregnant state; whether this increase in protein 239 
level corresponded to an increase in enzyme activity in this state, or with brain DHEA(S) levels, 240 
was not assessed. Conversely, in rats, neither STS brain activity nor sulfotransferase liver 241 
activity appear to be affected by pregnancy or parturition although only cortical (as opposed 242 
to whole) brain tissue was analysed (Maayan et al. 2004a). Interestingly, data on STS activity 243 
in rat leukocytes partially resemble those seen in humans, in that activity is significantly higher 244 
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in late-pregnancy animals (18 days post conception) than in non-pregnant animals, and 245 
activity becoming even more pronounced 24hrs after giving birth (Maayan et al. 2004a). In 246 
rat serum and brain cortex, the DHEA/DHEAS ratio is significantly, and equivalently, elevated 247 
in late pregnancy and early postpartum animals compared to non-pregnant control females 248 
(Maayan et al. 2004a).    249 
In summary, the sparse human and rodent data presented above are reconcilable with 250 
the proposal that in non-cortical regions of the mammalian brain, and in certain cells of the 251 
immune system, STS levels/activity increase over the course of pregnancy before peaking 252 
during late pregnancy and into the early postpartum period.  253 
A possible role for the steroid sulfate axis in normal maternal behavior 254 
Androgen-related metabolic pathways, including the STS/DHEA(S) axis, are known to 255 
modulate physiological processes asociated with parturition (Makieva et al. 2014). Given the 256 
previously-described role of the steroid sulfatase axis in brain and behavioral function, its 257 
increased activity in the perinatal period may be related to, and potentially be causal for, the 258 
emergence of maternal behaviors designed to nourish and protect their offspring. These 259 
behaviors, many of which are highly-conserved across mammalian species, include: nest-260 
building, huddling, nursing and social interaction with the offspring mediated by olfactory, 261 
visual, auditory and somatosensory cues, altered (generally decreased) levels of anxiety with 262 
increased exploratory behavior, and aggression directed towards threatening 263 
predators/society members but not offspring (Bridges 2015, Lonstein et al. 2015). In rodents, 264 
and probably also in humans, the quality and intensity of expressed maternal behaviors is 265 
related to maternal cognitive (executive) function, particularly in the domains of offspring-266 
related learning and memory processes, attention to relevant care cues, behavioral flexibility 267 
and impulse regulation; interestingly, in rats, reduced maternal behavior is associated with 268 
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impaired performance on attentional set-shifting and startle/prepulse inhibition tasks, whilst 269 
increased maternal care (pup-licking) is related to reduced motor impulsivity (Lonstein et al. 270 
2015). In non-primate species, and in primates to a lesser extent, these behaviors are driven 271 
by hormonal mechanisms acting via a multitude of brain regions and neurochemical systems, 272 
including the prefrontal cortex, the amygdala, the cholinergic basal forebrain activating 273 
system and the GABAergic and serotonergic systems (Bridges 2015, Lonstein et al. 2015). The 274 
fact that manipulation of the STS axis in males affects many of the cognitive/behavioral 275 
phenotypes and neurobiological systems listed above (notably attention, social interaction, 276 
emotional reactivity, aggression, memory, behavioral flexibility and motor impulsivity 277 
(Mortaud et al. 1996, Rhodes et al. 1997, Kent et al. 2008, Davies et al. 2009, Trent et al., 278 
2012a,2012b, Trent et al. 2013, Davies et al. 2014, Chatterjee et al. 2016)) supports the 279 
argument that the STS axis influences neural processes pertinent to maternal care efficacy in 280 
females. To explicitly test the idea that the STS axis influences maternal perinatal behavior, 281 
studies will need to be undertaken in non-pregnant (control), pregnant and postpartum 282 
female animal models and human subjects in which STS activity is compromised, or in which 283 
DHEA(S) levels are systematically varied and assayed.    284 
To date, the only available Sts-deficient genetic rodent models have been 285 
chromosomally-mutant mice that are necessarily male (Trent et al. 2012b), but new gene 286 
editing technology should hopefully allow the generation of Sts-deficient female rodents 287 
(Baud & Flint 2017). The expectation that such genetically-modified female rodents may 288 
exhibit STS-dependent abnormal maternal behaviors has been raised by a recent 289 
pharmacological study in our laboratory. Briefly, we showed that acute inhibition of STS in 290 
new mouse mothers resulted in anxiety-related phenotypes (a reduced startle response, and 291 
increased rearing and exploratory drive on the elevated plus maze), but no gross 292 
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abnormalities in nest maintenance or in mother-pup interactions (Humby et al. 2016). At this 293 
stage, we cannot discount the fact that there were subtle, undetectable, irregularities in dam-294 
pup interactions, especially in light of the fact that inhibitor-treated mothers exhibit 295 
substantial dysregulation of olfactory-related gene expression in the brain (W Davies, 296 
unpublished results). Furthermore, as we did not examine the behavioral effects of acute STS 297 
inhibition in female mice with other physiological statuses (virgin, non-virgin but non-298 
pregnant, and pregnant), we cannot definitively say that the behavioral effects mediated by 299 
the STS axis are specific to the postpartum period; this extended analysis is ongoing. We are 300 
currently undertaking a parallel systematic study of behavior, including perinatal behavior, in 301 
STS-deficient women with a view to determining which, if any, psychological processes are 302 
affected by their genetic mutation.  303 
Additional evidence that DHEA(S) participate in normal perinatal maternal behaviors 304 
in humans may be obtained by showing behavioral effects elicited by administration to new 305 
mothers, or through identifying significant correlations between systemic DHEA(S) levels and 306 
behavioral/cognitive measures in healthy (or general population) postpartum mothers. 307 
Although DHEAS administration has been performed in postpartum women (e.g. Aisaka et al. 308 
1984) there is no reliable published data available regarding parallel behavioral changes. In 309 
healthy women selected from the general population, there is some evidence for an 310 
association between higher serum DHEA levels, enhanced mood and aspects of better 311 
cognitive performance during late pregnancy (~20 days prior to delivery) and the postpartum 312 
period (~26 days after delivery) (Buckwalter et al. 1999), although no similar relationship 313 
seems to exist for DHEAS levels (Farrar et al. 2014).      314 
 315 
 316 
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Postpartum psychiatric disorders 317 
A significant proportion of women experience mental health issues manifesting in late 318 
pregnancy and/or in the postpartum period. These can range from relatively common and 319 
comparatively mild conditions which do not require medical intervention (so-called ‘baby 320 
blues’) to rarer, more severe, persistent and disabling disorders which require urgent medical 321 
care; the latter category of disorders includes postpartum depression, obsessive-compulsive 322 
disorder and anxiety disorders (Sharma & Sommerdyk 2015, Stewart & Vigod 2016, Pawluski 323 
et al. 2017). If the steroid sulfate axis is indeed a major player in maternal brain and behavioral 324 
function in late pregnancy and the postpartum period as has been argued above, then, 325 
logically, its dysfunction might reasonably be considered a risk factor for vulnerability to 326 
maternal mental health conditions in this period. In the following section, I discuss the nature 327 
and aetiology of one extremely severe and poorly-understood psychiatric disorder associated 328 
with childbirth, postpartum (or puerperal) psychosis, and consider evidence implicating 329 
steroid sulfate axis abnormalities in its pathogenesis.  330 
The nature and etiology of postpartum psychosis 331 
Postpartum psychosis (PP) is estimated to affect 1-2 in every 1000 new mothers (VanderKruik 332 
et al. 2017). Symptoms associated with the condition include hallucinations, delusions (often 333 
related to the newborn child), cognitive disorganisation, anxiety, and mood abnormalities, 334 
and these tend to present within the first two weeks (and frequently within the first few days) 335 
of childbirth; PP symptoms can impact massively upon normal mother-child bonding and 336 
family life, and affected mothers are at elevated risk of commiting suicide or infanticide 337 
(Bergink et al. 2016). Whilst there is thought to be a considerable biological component to 338 
disorder vulnerability, the exact nature and contribution of underlying biological risk factors 339 
is currently obscure (Jones et al. 2014, Bergink et al. 2016). Understanding these may help to 340 
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develop better predictive biomarkers for the condition, as well as more effective and safer 341 
treatment options (Davies 2017). Epidemiological data has suggested considerable overlap 342 
with bipolar disorder, autoimmune thyroid conditions, and pre-eclampsia (Jones et al. 2014, 343 
Bergink et al. 2016); other studies have implicated an abnormal (over-active) immune system 344 
(Bergink et al. 2013, Kumar et al. 2017), autoimmune anti-NMDA receptor encephalitis 345 
(Bergink et al. 2015), and serotonergic system dysfunction (Kumar et al. 2007, Davies 2017) 346 
in risk. A genetic linkage study in bipolar postpartum psychosis implicated significant and 347 
suggestive loci at 16p13 and 8q24 respectively (Jones et al. 2007), but, to date, findings from 348 
small-scale (and therefore underpowered) candidate gene and genome-wide association 349 
studies have been unconvincing or non-significant, and none have yet implicated X-linked 350 
genetic risk variants.  351 
Steroid sulfate axis dysfunction and postpartum psychosis risk 352 
There are several lines of basic and clinical evidence suggesting that abnormalities with the 353 
steroid sulfate axis (and most likely steroid sulfatase deficiency (Davies 2012)) may influence 354 
PP risk: a) the axis appears to exert disproportionately large effects in the late 355 
pregnancy/early postpartum period, so any disruption to it may impact relatively specifically 356 
on this timepoint, b) estrogens are generally thought to be protective against psychosis 357 
(Reicher-Rossler 2017) and STS deficiency, in women, as in men (Lykkesfeldt et al. 1985), is 358 
expected to result in lower levels of circulating estrogens as a consequence of reduced levels 359 
of DHEA precursor, c) genetic deletions encompassing STS have been associated with 360 
psychotic disorders (paranoid and early-onset schizophrenia) in case studies (Milunsky et al. 361 
1999, Malik et al. 2017), d) STS brain expression is high in regions previously implicated in 362 
psychotic disorders (Fusar-Poli et al. 2011, Dietsche et al. 2017), e) the neurochemical 363 
abnormalities associated with psychosis and remediable by antipsychotic treatment overlap 364 
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considerably with those influenced by STS and DHEA(S) i.e. of the serotonergic system 365 
(notably the 5-HT2C receptor)(Meltzer et al. 2012, Selvaraj et al. 2014), the hippocampal 366 
cholinergic system (Olincy & Freedman 2012, Carruthers et al. 2015), the GABAA system 367 
(Egerton et al. 2017), and of NMDA receptor signalling (notably in the thalamus)(Vukadinovic  368 
2014, Harrison 2015), f) STS-deficient humans and mice exhibit a range of PP-relevant 369 
phenotypes including inattention and emotional instability, whilst genetic variants within STS 370 
in man are associated with cognitive disorganisation (see above), g) STS is highly-expressed in 371 
the hypothalamus, pituitary gland and the thyroid gland (Stergiakouli et al. 2011) and its 372 
absence in these tissues could potentially explain high rates of hypothalamus-pituitary-373 
thyroid axis dysfunction and autoimmune thyroid dysfunction in PP, h) abnormal placental 374 
and whole blood STS expression is associated with pre-eclampsia (Gratton et al. 2016), i) 375 
levels of salivary DHEAS during late pregnancy and in the early postpartum period (10 days 376 
after birth) positively correlate with measures of anxiety, phobia, paranoia and psychoticism 377 
in previously-healthy women, with highest DHEAS levels (consistent with impaired or absent 378 
STS activity) being associated with significant psychiatric distress (Marrs et al. 2009, Marrs et 379 
al. 2010), j) lithium, an established effective treatment for mania in bipolar disorder and PP, 380 
enhances the serum DHEA/DHEAS ratio in rats consistent with a stimulatory effect on STS, 381 
whilst reducing both brain and serum levels of DHEAS (Maayan et al. 2004b), k) pathologically-382 
reduced levels of immunosuppressive DHEA in the postpartum period as a consequence of 383 
STS deficiency may feasibly contribute towards the immune hyper-activation seen in PP and 384 
l) STS and the HTR2C (5-HT2C) gene lie under candidate quantitative trait loci linkage peaks in 385 
a porcine model of PP (Quilter et al. 2007). Finally, the prevalence of STS deficiency i.e. 386 
heterozygosity or homozygosity for null mutations in women is estimated to be ~1 in 950 387 
individuals (based upon the general population frequency of STS deficiency in males (Langlois 388 
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et al. 2009, Craig et al. 2010) and de novo versus inherited mutation rates (Cuevas-389 
Covarrubias et al. 1999)); this rate is consistent with it being a risk factor for PP, although 390 
clearly, as for most mood and psychotic disorders, multiple interacting genetic and 391 
environmental risk factors are likely to influence overall PP vulnerability.            392 
Future analyses, in STS-deficient women or in Sts-deficient female rodents, are likely 393 
to provide evidence for or against the hypothesis that this molecular perturbation increases 394 
PP risk, although such studies will likely be limited by available sample size, by the infrequency 395 
of the condition, and by cross-species extrapolation issues. Further studies in healthy women 396 
in late pregnancy and the postpartum period, which will be less constrained by sample size, 397 
might examine if, and how, peripheral steroid sulfatase activity (in addition to DHEA(S) levels) 398 
correlate with dimensional behavioral measures related to PP (e.g. psychoticism). Alternative 399 
complementary work in clinical PP populations might investigate: a) variability within the STS 400 
gene (where rates of causal polymorphisms/mutations might be expected to differ from 401 
control women), b) STS activity in accessible tissues such as leukocytes (lower activity 402 
anticipated in women affected by PP than in controls) or c) peripheral baseline and stress-403 
evoked levels of DHEA(S)(higher DHEAS/DHEA ratios expected in affected women versus 404 
control subjects).   405 
Our mouse studies have provided preliminary evidence somewhat supportive of the 406 
notion of STS deficiency as a risk factor for PP. Briefly, we found that the behavioral 407 
phenotypes elicited by STS inhibition in new mothers could be partially reversed by 408 
administration of the clinically-efficacious antipsychotic drug ziprasidone, thus indicating 409 
their potential relevance to PP (Humby et al. 2016). Additionally, and intriguingly, STS-410 
inhibited mice demonstrated abnormal gene expression within a small region of chromosome 411 
15 (equivalent to the 8q24 candiate genomic region implicated by linkage in PP), which could 412 
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also be normalised by ziprasidone administration, providing further support for the model’s 413 
face and predictive validity and thus its utility for understanding the mechanistic basis of PP 414 
risk (Humby et al. 2016).     415 
Steroid sulfate axis dysfunction in other postpartum psychiatric disorders 416 
Postpartum psychosis is an umbrella term covering a wide variety of behavioral and 417 
psychiatric symptoms, in addition to psychosis, that present shortly after childbirth. Many of 418 
these symptoms (which can include depressive and manic episodes, anxiety and obsessive-419 
compulsive tendencies) may also be seen, to varying extents, in cases of other differentially-420 
defined postpartum psychiatric conditions such as postpartum depression, and could be 421 
underpinned by common biological processes. Much of the logic implicating steroid sulfate 422 
axis dysfunction in general, and STS deficiency in particular, in PP pathophysiology may be 423 
equally applied to these alternative disorders, especially considering that their occurrence 424 
may, in part, be due to abnormalities in physiological and neurochemical systems affected by 425 
this axis i.e. steroid hormone levels, the hypothalamic-pituitary-adrenal axis, the thyroid 426 
system, markers of inflammation and the GABAergic, noradrenergic and serotonergic systems 427 
(Speisman et al. 2011, Skalkidou et al. 2012, Pawluski et al. 2017). The observed effects of STS 428 
deficiency on mood modulation (Chatterjee et al. 2016), behavioral (in)flexibility (Trent et al. 429 
2013) and anxiety-related processes (Trent et al. 2012b, Chatterjee et al. 2016) implicate it as 430 
a candidate risk factor in postpartum depression, OCD, and anxiety respectively.  The steroid 431 
sulfate axis could also feasibly mediate the effects of environmental factors (e.g. stressors 432 
such as childhood maltreatment) on mothers’ vulnerability to a range of postpartum 433 
psychiatric illnesses, and potentially even on their infants health (Sexton et al. 2015, Schury 434 
et al. 2017).      435 
 436 
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Evidence examining rates of these various postpartum psychiatric conditions and 437 
associated behavioral and physiological markers remains to be collected in STS-deficient 438 
individuals and animal models; conversely, rates of STS deficiency remain to be determined 439 
in patients ascertained on the basis of having been diagnosed with such postpartum 440 
conditions. However, there is some limited existing data, consistent with the STS deficiency 441 
risk hypothesis, suggesting that circulating maternal DHEA plasma levels may be abnormally 442 
low prior to, and during the onset of, postpartum depression (Gelman et al. 2015), and that 443 
DHEA supplementation can benefit mood in depressed individuals (although consistent 444 
therapeutic benefits of this intervention in the postpartum period have yet to 445 
demonstrated)(Soares & Phillips 2006, Peixoto et al. 2014).       446 
Conclusions and future work 447 
Above I have discussed the mounting evidence (admittedly mainly obtained in male test 448 
subjects to date) that steroid sulfatase, and the reactions it catalyses, have important roles in 449 
a wide variety of important brain and behavioral functions. As the activity of the STS axis 450 
fluctuates across numerous tissues (including brain) during pregnancy, and into the 451 
postpartum period, it is conceivable that this axis bears upon normal maternal behavioral 452 
phenotypes and its influence in this respect remains to be tested using genetic and 453 
pharmacological approaches in clinical and model populations. In particular, gene expression 454 
changes elicited by manipulations of the steroid sulfate axis may be compared against those 455 
seen in the healthy postpartum maternal brain (Gammie et al. 2016). It also follows that, 456 
potentially, STS axis dysfunction may be associated with postpartum psychiatric conditions, 457 
and there is some circumstantial evidence, notably in postpartum psychosis, that this may be 458 
the case. Genetic and endocrine analyses in women previously affected by, or at high of 459 
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developing, postpartum psychiatric conditions should be able to experimentally test this 460 
hypothesis.   461 
Of course, whilst I have focussed upon the possible impact of STS and DHEA(S) on 462 
maternal behavior here, it is naïve to think that these molecules act in isolation to affect this 463 
phenotype. As such, future studies should aim to supplement the currently available, very 464 
limited, data relating to the brain and peripheral expression and activity of enzymes and 465 
compounds involved in DHEA(S) biosynthesis and metabolism (notably the SULTs and SUMFs) 466 
across pregnancy and the postpartum period in healthy women, women affected by 467 
postpartum psychiatric illness, and relevant mammalian animal models, with a view to 468 
understanding how these components interact to generate healthy or abnormal behaviours. 469 
Work in model systems in particular may highlight molecules and pathways which mediate 470 
the behavioral effects of the steroid sulfate axis, and which could theoretically comprise novel 471 
therapeutic targets. For example, our nascent mouse work has implicated the CCN family of 472 
proteins as potentially-druggable targets in cases of PP (Davies, 2017). Pharmacological or 473 
genetic targeting of such mediators might result in lower levels of side-effects compared to 474 
the systemic administration of compounds such as DHEA or estrogens which have 475 
androgenic/estrogenic potential and which elicit widespread effects on multiple physiological 476 
systems (Gentile 2005,  Rutkowski et al. 2014).   477 
 478 
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 481 
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